Platelet-activating factor-acetylhydrolase activity in follicular fluid of patients undergoing in vitro fertilization and embryo transfer. 1995

H Narahara, and Y Tanaka, and Y Kawano, and K Gholbzouri, and I Miyakawa, and J M Johnston
Department of Obstetrics and Gynecology, Oita Medical University, Japan.

OBJECTIVE To examine the role of platelet-activating factor (PAF) metabolism in the periovulatory processes. METHODS The PAF-acetylhydrolase activity in the follicular fluid (FF) obtained in conjunction with IVF-ET procedure was assayed and its activity was related to oocyte maturation. The PAF-acetylhydrolase activity also was related to the concentration of various ovarian hormones. METHODS All patients were managed and treated at Oita Medical University Hospital, Oita, Japan. METHODS The study concerned 30 women between 28 and 36 years of age with tubal infertility. METHODS The activity of PAF-acetylhydrolase in FF was assayed as well as E2 and P. Oocyte maturation also was evaluated. RESULTS Platelet-activating factor-acetylhydrolase activity was decreased significantly in the FFs of patients with a successful outcome of their pregnancies compared with the nonsuccessful group. Estradiol levels were negatively correlated with PAF-acetylhydrolase activities in the FFs. No correlation was found between the PAF-acetylhydrolase activity and P concentration in the FF. Significantly more mature and less immature oocytes were recovered in the group who subsequently became pregnant compared with the nonpregnant group. CONCLUSIONS It is suggested that the decrease in PAF-acetylhydrolase activity may result in an increase of PAF in the FFs, which in turn may contribute to a successful pregnancy. The determination of PAF-acetylhydrolase activity in FF may serve as a prognostic marker for the evaluation of oocytes that are utilized in IVF-ET procedure.

UI MeSH Term Description Entries
D007247 Infertility, Female Diminished or absent ability of a female to achieve conception. Sterility, Female,Sterility, Postpartum,Sub-Fertility, Female,Subfertility, Female,Female Infertility,Female Sterility,Female Sub-Fertility,Female Subfertility,Postpartum Sterility,Sub Fertility, Female
D010741 Phospholipases A Phospholipases that hydrolyze one of the acyl groups of phosphoglycerides or glycerophosphatidates.
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011256 Pregnancy Outcome Results of conception and ensuing pregnancy, including LIVE BIRTH; STILLBIRTH; or SPONTANEOUS ABORTION. The outcome may follow natural or artificial insemination or any of the various ASSISTED REPRODUCTIVE TECHNIQUES, such as EMBRYO TRANSFER or FERTILIZATION IN VITRO. Outcome, Pregnancy,Outcomes, Pregnancy,Pregnancy Outcomes
D011374 Progesterone The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS. Pregnenedione,Progesterone, (13 alpha,17 alpha)-(+-)-Isomer,Progesterone, (17 alpha)-Isomer,Progesterone, (9 beta,10 alpha)-Isomer
D004624 Embryo Transfer The transfer of mammalian embryos from an in vivo or in vitro environment to a suitable host to improve pregnancy or gestational outcome in human or animal. In human fertility treatment programs, preimplantation embryos ranging from the 4-cell stage to the blastocyst stage are transferred to the uterine cavity between 3-5 days after FERTILIZATION IN VITRO. Blastocyst Transfer,Tubal Embryo Transfer,Tubal Embryo Stage Transfer,Embryo Transfers,Transfer, Embryo,Transfers, Embryo
D004958 Estradiol The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. 17 beta-Estradiol,Estradiol-17 beta,Oestradiol,17 beta-Oestradiol,Aerodiol,Delestrogen,Estrace,Estraderm TTS,Estradiol Anhydrous,Estradiol Hemihydrate,Estradiol Hemihydrate, (17 alpha)-Isomer,Estradiol Monohydrate,Estradiol Valerate,Estradiol Valeriante,Estradiol, (+-)-Isomer,Estradiol, (-)-Isomer,Estradiol, (16 alpha,17 alpha)-Isomer,Estradiol, (16 alpha,17 beta)-Isomer,Estradiol, (17-alpha)-Isomer,Estradiol, (8 alpha,17 beta)-(+-)-Isomer,Estradiol, (8 alpha,17 beta)-Isomer,Estradiol, (9 beta,17 alpha)-Isomer,Estradiol, (9 beta,17 beta)-Isomer,Estradiol, Monosodium Salt,Estradiol, Sodium Salt,Estradiol-17 alpha,Estradiol-17beta,Ovocyclin,Progynon-Depot,Progynova,Vivelle,17 beta Estradiol,17 beta Oestradiol,Estradiol 17 alpha,Estradiol 17 beta,Estradiol 17beta,Progynon Depot
D005184 Fallopian Tube Diseases Diseases involving the FALLOPIAN TUBES including neoplasms (FALLOPIAN TUBE NEOPLASMS); SALPINGITIS; tubo-ovarian abscess; and blockage. Tubal Obstruction,Disease, Fallopian Tube,Diseases, Fallopian Tube,Fallopian Tube Disease,Obstruction, Tubal,Obstructions, Tubal,Tubal Obstructions
D005260 Female Females
D005307 Fertilization in Vitro An assisted reproductive technique that includes the direct handling and manipulation of oocytes and sperm to achieve fertilization in vitro. Test-Tube Fertilization,Fertilizations in Vitro,In Vitro Fertilization,Test-Tube Babies,Babies, Test-Tube,Baby, Test-Tube,Fertilization, Test-Tube,Fertilizations, Test-Tube,In Vitro Fertilizations,Test Tube Babies,Test Tube Fertilization,Test-Tube Baby,Test-Tube Fertilizations

Related Publications

H Narahara, and Y Tanaka, and Y Kawano, and K Gholbzouri, and I Miyakawa, and J M Johnston
February 1997, American journal of reproductive immunology (New York, N.Y. : 1989),
H Narahara, and Y Tanaka, and Y Kawano, and K Gholbzouri, and I Miyakawa, and J M Johnston
December 2012, Systems biology in reproductive medicine,
H Narahara, and Y Tanaka, and Y Kawano, and K Gholbzouri, and I Miyakawa, and J M Johnston
January 2008, Journal of assisted reproduction and genetics,
H Narahara, and Y Tanaka, and Y Kawano, and K Gholbzouri, and I Miyakawa, and J M Johnston
April 1993, Fertility and sterility,
H Narahara, and Y Tanaka, and Y Kawano, and K Gholbzouri, and I Miyakawa, and J M Johnston
January 2004, Gynecologic and obstetric investigation,
H Narahara, and Y Tanaka, and Y Kawano, and K Gholbzouri, and I Miyakawa, and J M Johnston
July 2022, American journal of reproductive immunology (New York, N.Y. : 1989),
H Narahara, and Y Tanaka, and Y Kawano, and K Gholbzouri, and I Miyakawa, and J M Johnston
June 2005, Critical care medicine,
H Narahara, and Y Tanaka, and Y Kawano, and K Gholbzouri, and I Miyakawa, and J M Johnston
August 2002, Prostaglandins & other lipid mediators,
H Narahara, and Y Tanaka, and Y Kawano, and K Gholbzouri, and I Miyakawa, and J M Johnston
June 2012, Biomedica : revista del Instituto Nacional de Salud,
H Narahara, and Y Tanaka, and Y Kawano, and K Gholbzouri, and I Miyakawa, and J M Johnston
August 1987, Human reproduction (Oxford, England),
Copied contents to your clipboard!